These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4999877)

  • 21. Immune response of vaccinated and non-vaccinated mice to Coccidioides posadasii infection.
    Xue J; Hung CY; Yu JJ; Cole GT
    Vaccine; 2005 May; 23(27):3535-44. PubMed ID: 15855012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An immunologic evaluation of several Coccidioides immitis antigens].
    Semakova NG
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Aug; 47(8):56-9. PubMed ID: 5503343
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune responses in coccidioidomycosis.
    Levine HB
    Mykosen Suppl; 1978; 1():280-4. PubMed ID: 299487
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
    Herr RA; Hung CY; Cole GT
    Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
    Hung CY; Wozniak KL; Cole GT
    Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coccidioidomycosis: host response and vaccine development.
    Cox RA; Magee DM
    Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Course of coccidioidomycosis in intratracheally infected guinea pigs.
    Cox RA; Pavey EF; Mead CG
    Infect Immun; 1981 Feb; 31(2):679-86. PubMed ID: 7216468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The present status of vaccination against coccidioidomycosis in man.
    Pappagianis D; Levine HB
    Am J Epidemiol; 1975 Jul; 102(1):30-41. PubMed ID: 1155435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.
    Shubitz L; Peng T; Perrill R; Simons J; Orsborn K; Galgiani JN
    Infect Immun; 2002 Jun; 70(6):3287-9. PubMed ID: 12011027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppression by cell wall antigens of Coccidioides immitis.
    Cox RA
    Rev Infect Dis; 1988; 10 Suppl 2():S415-8. PubMed ID: 3263691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivalent recombinant protein vaccine against coccidioidomycosis.
    Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
    Infect Immun; 2006 Oct; 74(10):5802-13. PubMed ID: 16988258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice.
    Fierer J; Waters C; Walls L
    J Infect Dis; 2006 May; 193(9):1323-31. PubMed ID: 16586371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules.
    Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D
    Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic impairment in mice treated intravenously with killed Coccidioides immitis spherules: suppressed response to intramuscular doses.
    Levine HB; Kong YC
    J Immunol; 1966 Sep; 97(3):297-305. PubMed ID: 5925701
    [No Abstract]   [Full Text] [Related]  

  • 35. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
    Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
    J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
    Pappagianis D
    Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties and assay of spherulins from Coccidioides immitis in delayed sensitivity responses of animals.
    Scalarone GM; Levine HB; Chaparas SD; Cobb JM
    Sabouraudia; 1973 Nov; 11(3):222-34. PubMed ID: 4765980
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
    Kirkland TN; Raz E; Datta SK
    Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on Coccidioides immitis. XVII: Morphology of the parasite in relationship with the host immunoallergic condition in the experimental infection of the guinea-pig.
    Negroni P; Besuschio S; Negroni R; Beatriz M; Negroni de Bonvehi MB
    Mycopathol Mycol Appl; 1974 Jan; 52(1):1-11. PubMed ID: 4365831
    [No Abstract]   [Full Text] [Related]  

  • 40. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.